Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion type Assertion NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_head.
- NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion description "[Furthermore, immunohistochemical analysis of ovarian tumor tissue microarray detected aberrant ALK expression in 2% to 4% serous carcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_provenance.
- NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion evidence source_evidence_literature NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_provenance.
- NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion SIO_000772 22570254 NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_provenance.
- NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion wasDerivedFrom befree-2016 NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_provenance.
- NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_assertion wasGeneratedBy ECO_0000203 NP980660.RAlAyGkc5H_SKp4sMjFe5FQpNucwfqsrT6Gobu62OUXIo130_provenance.